Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer
Clinical trial NCT02383251 · COMPLETED
Trial details
- NCT number
- NCT02383251
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-15
- Primary completion
- 2019-08-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.